Frequent exposure to suboptimal temperatures in vaccine cold-chain system in india: Results of temperature monitoring in 10 states;Exposition fréquente à des températures suboptimales dans la chaîne du froid des vaccins en Inde: Résultats du suivi des températures dans 10 états

Bulletin of the World Health Organization

Volumn 91, Issue 12, 2013, Pages 906-913

  Murhekar, Manoj V ^a   Dutta, Srihari ^b   Kapoor, Ambujam Nair ^a   Bitragunta, Sailaja ^c   Dodum, Raja ^d   Ghosh, Pramit ^e   Swamy, Karumanagounder Kolanda ^f   Mukhopadhyay, Kalyanranjan ^g   Ningombam, Somorjit ^h   Parmar, Kamlesh ⁱ   Ravishankar, Devegowda ^j   Singh, Balraj ^k   Singh, Varsha ^l   Sisodiya, Rajesh ^m   Subramanian, Ramaratnam ^f   Takum, Tana ^d  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNITED NATIONS CHILDREN'S FUND   (India)

^c Government of Andhra Pradesh   (India)

^d Department of Environment and Forests   (India)

^e MEDICAL COLLEGE AND HOSPITAL   (India)

^f Tamilnadu Hospital   (India)

^g Government of West Bengal   (India)

^h Manipur Institute of Technology   (India)

ⁱ Government of India)   (India)

^j Government of Karnataka   (India)

^k INDIRA GANDHI MEDICAL COLLEGE   (India)

^l State Institute of Health and Family Welfare Government of Bihar   (India)

^m Government of Madhya Pradesh   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; VACCINE;

ARTICLE; HEALTH CARE FACILITY; HEALTH CENTER; POWER SUPPLY; PREVENTIVE HEALTH SERVICE; QUESTIONNAIRE; REFRIGERATOR; STORAGE TEMPERATURE; TEMPERATURE MEASUREMENT; TRAFFIC AND TRANSPORT; DRUG STORAGE; FREEZING; HUMAN; INDIA; STATISTICS AND NUMERICAL DATA; TEMPERATURE;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG STORAGE; HUMANS; INDIA; REFRIGERATION; TEMPERATURE; TRANSPORTATION; VACCINES;

EID: 84888626994     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.119974     Document Type: Article

References (23)

1. World development report: investing in health. New York: Oxford University Press; 1993.
2. Study protocol for temperature monitoring in the vaccine cold chain. Geneva: World Health Organization; 2011.
3. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006.
4. Galazka A, Milstien J, Zafran M. Thermostability of vaccines. Geneva: World Health Organization; 1998.
5. Boros CA, Hanlon M, Gold MS, Roberton DM. Storage at -3°C for 24 h alters the immunogenicity of pertussis vaccines. Vaccine 2001;19:3537-3542. doi: http://dx.doi.org/10.1016/S0264-410X(01)00063-9 PMID:11348721
6. Ho MM, Mawas F, Bolgiano B, Lemercinier X, Crane DT, Huskisson R et al. Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines. Vaccine 2002;20:3509-3522. doi: http:// dx.doi.org/10.1016/S0264-410X(02)00342-0 PMID:12297396
7. Bolgiano B, Mawas F, Yost SE, Crane DT, Lemercinier X, Corbel MJ. Efect of physico-chemical modifcation on the immunogenicity of Haemophilus infuenzae type b oligosaccharide-CRM(197) conjugate vaccines. Vaccine 2001;19:3189-3200. doi: http://dx.doi.org/10.1016/S0264-410X(01)00024-X PMID:11312015
8. Diminsky D, Moav N, Gorecki M, Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999;18:3-17. doi: http://dx.doi.org/10.1016/S0264-410X(99)00149-8 PMID:10501230
9. World Health Organization. Expanded Programme on Immunization. The effects of freezing on the appearance, potency, and toxicity of adsorbed and unadsorbed DTP vaccines. Wkly Epidemiol Rec 1980;55:385-392.
10. Handbook for vaccine and cold chain handlers. New Delhi: Ministry of Health and Family Welfare; 2010. Available from: http://www.unicef.org/india/Cold_chain_book_Final_(Corrected19-04-10).pdf [accessed 20 June 2013].
11. Samant Y, Lanjewar H, Parker D, Block L, Tomar GS, Stein B. Evaluation of the cold-chain for oral polio vaccine in a rural district of India. Public Health Rep 2007;122:112-121. PMID:17236617
12. Goel NK, Pathak R, Galhotra A, Dankal C, Swami HM. Status of cold-chain maintenance in Chandigarh. Indian J Public Health 2008;52:37-39. PMID:18700720
13. Galhotra A, Goel NK, Pathak R, Kumar R, Swami HM. Surveillance of cold chain system during intensifed pulse polio programme - 2006 in Chandigarh. Indian J Pediatr 2007;74:751-753. doi: http://dx.doi.org/10.1007/ s12098-007-0132-9 PMID:17785898
14. Kartoglu U, Ozgüler NK, Wolfson LJ, Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Organ 2010;88:624-631. doi: http://dx.doi.org/10.2471/BLT.08.056879 PMID:20680128
15. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007;25:3980-3986. doi: http://dx.doi.org/10.1016/j. vaccine.2007.02.052 PMID:17382434
16. Training for middle-level managers: cold chain, vaccines and safe-injection equipment management. Geneva: World Health Organization; 2008. Available from: http://www.who.int/immunization_delivery/systems_ policy/MLM_module1.pdf [accessed 20 June 2013].
17. Nelson C, Froes P, Dyck AM, Chavarría J, Boda E, Coca A et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007;25:433-437. doi: http://dx.doi.org/10.1016/j.vaccine.2006.08.017 PMID:17000036
18. Braun LJ, Tyagi A, Perkins S, Carpenter J, Sylvester D, Guy M et al. Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants. Vaccine 2009;27:72-79. doi: http://dx.doi. org/10.1016/j.vaccine.2008.10.027 PMID:18973782
19. Menon PS, Sahai G, Joshi VB, Murthy RG, Boparai MS, Thomas AK. Field trial on frozen and thawed tetanus toxoid. Indian J Med Res 1976;64:25-32. PMID:1270098
20. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and efectiveness among urban and rural Mongolian 2-year-olds. Prev Med 2002;34:207-214. doi: http:// dx.doi.org/10.1006/pmed.2001.0972 PMID:11817916
21. Edstam JS, Dulmaa N, Tsendjav O, Dambasuren B, Densmaa B. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 2004;39:384-388. doi: http://dx.doi. org/10.1016/j.ypmed.2004.01.029 PMID:15226050
22. Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines 2009;8:547-557. doi: http:// dx.doi.org/10.1586/erv.09.20 PMID:19397412
23. Lee BY, Cakouros BE, Assi TM, Connor DL, Welling J, Kone S et al. The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 2012;30:5637-5643. doi: http://dx.doi.org/10.1016/j.vaccine.2012.06.087 PMID:22789507